Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Sumeray

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Basic Research in Cardiology|December 2, 1998
Ischaemic preconditioning reduces infarct size following global ischaemia in the murine myocardiumM S Sumeray, D M Yellon
European Heart Journal|January 1, 1997
Myocardial preconditioning. What have we learned?M S Sumeray, D M Yellon
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 1, 1995
Pulmonary amyloidosis occurring after heart transplantation for amyloid heart diseaseM S Sumeray, A J Murday
Molecular and Cellular Biochemistry|October 17, 1998
Characterisation and validation of a murine model of global ischaemia-reperfusion injuryM S Sumeray, D M Yellon
Hospital Medicine (London, England : 1998)|August 29, 1998
Ischaemic preconditioning: a clinical perspectiveA Dana, M S Sumeray, D M Yellon
Cardiovascular Drugs and Therapy|October 24, 1998
Beyond coagulation: fibrinogen as a cause of cardiovascular surgical diseaseM S Sumeray, H E Montgomery, S E Humphries
Lancet (London, England)|November 23, 1996
Infarct size and magnesium: insights into LIMIT-2 and ISIS-4 from experimental studiesG F Baxter, M S Sumeray, J M Walker
Journal of Molecular and Cellular Cardiology|February 1, 2000
Infarct size and nitric oxide synthase in murine myocardiumM S Sumeray, D D Rees, D M Yellon
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1993
Multiple myeloma presenting as an acute abdomenM S Sumeray, M S Hamilton, J D Dubois, et al.
Cardiovascular Research|April 16, 1998
Ischaemic preconditioning: present position and future directionsD M Yellon, G F Baxter, D Garcia-Dorado, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Basic Research in Cardiology|December 2, 1998
Ischaemic preconditioning reduces infarct size following global ischaemia in the murine myocardiumM S Sumeray, D M Yellon
European Heart Journal|January 1, 1997
Myocardial preconditioning. What have we learned?M S Sumeray, D M Yellon
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 1, 1995
Pulmonary amyloidosis occurring after heart transplantation for amyloid heart diseaseM S Sumeray, A J Murday
Molecular and Cellular Biochemistry|October 17, 1998
Characterisation and validation of a murine model of global ischaemia-reperfusion injuryM S Sumeray, D M Yellon
Hospital Medicine (London, England : 1998)|August 29, 1998
Ischaemic preconditioning: a clinical perspectiveA Dana, M S Sumeray, D M Yellon
Cardiovascular Drugs and Therapy|October 24, 1998
Beyond coagulation: fibrinogen as a cause of cardiovascular surgical diseaseM S Sumeray, H E Montgomery, S E Humphries
Lancet (London, England)|November 23, 1996
Infarct size and magnesium: insights into LIMIT-2 and ISIS-4 from experimental studiesG F Baxter, M S Sumeray, J M Walker
Journal of Molecular and Cellular Cardiology|February 1, 2000
Infarct size and nitric oxide synthase in murine myocardiumM S Sumeray, D D Rees, D M Yellon
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1993
Multiple myeloma presenting as an acute abdomenM S Sumeray, M S Hamilton, J D Dubois, et al.
Cardiovascular Research|April 16, 1998
Ischaemic preconditioning: present position and future directionsD M Yellon, G F Baxter, D Garcia-Dorado, et al.
Pageof 1